Carl A. Morris - Worldwide Research and Development, Pfizer Inc

基本信息

浏览量：2

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 61 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

N-terminal Titin Fragment: a Non-Invasive, Pharmacodynamic Biomarker for Microdystrophin Efficacy

Jessica F. Boehler,Kristy J. Brown,Valeria Ricotti,Carl A. Morris

SKELETAL MUSCLEno. 1 (2024)

引用0浏览0WOS引用

Clinical Potential of Microdystrophin As a Surrogate Endpoint

Jessica F. Boehler,Kristy J. Brown,Margaret Beatka,J. Patrick Gonzalez, Roxana Donisa Dreghici,Meghan Soustek-Kramer,Sharon McGonigle,Annie Ganot, Timothy Palmer, Caitlin Lowie,Jeffrey S. Chamberlain,Michael W. Lawlor,Carl A. Morris

Neuromuscular disordersno. 1 (2023): 40-49

引用1浏览0WOS引用

Characterization of Factors That Influence the Yield and Quality of AAV Produced Using HSV Co-Infection

Xiaofei E, Brian Collins, Ben Wright, Lauren Peters, Sviatlana Rose,Carl Morris,Sharon McGonigle

MOLECULAR THERAPYno. 4 (2023): 648-649

引用0浏览0引用

Dystrophin Immunity after Gene Therapy for Duchenne’s Muscular Dystrophy

Carsten G. Bönnemann,Beth A. Belluscio,Serge Braun,Carl Morris,Teji Singh,Francesco Muntoni

New England journal of medicine/The New England journal of medicineno. 24 (2023): 2294-2296

引用8浏览0引用

Microdystrophin Expression As a Surrogate Endpoint for Duchenne Muscular Dystrophy Clinical Trials

Jeffrey S. S. Chamberlain, Melissa Robb,Serge Braun,Kristy J. J. Brown,Olivier Danos,Annie Ganot,Pedro Gonzalez-Alegre, Nina Hunter,Craig McDonald,Carl Morris, Mark Tobolowsky,Kathryn R. R. Wagner, Olivia Ziolkowski,Dongsheng Duan

Human gene therapy（2023）

引用2浏览0WOS引用

Novel AAV Capsid Identification and Characterization for Neuromuscular and Cardiac Indications

Jennifer C. G. Green,Jessica F. Boehler,Meghan S. Soustek,Jamie L. Marshall,Tiffany Willacy, Prushti Bhavsar,Kristy J. Brown,Sharon McGonigle,Carl Morris

MOLECULAR THERAPYno. 4 (2023): 728-729

引用0浏览0引用

Considerations in Establishing Meaningful Clinical Endpoints in Duchenne Muscular Dystrophy & Other Neuromuscular Disorders

Carl A. Morris, Roxana Donisa Dreghici,J. Patrick Gonzalez

Cell & gene therapy insightsno. 01 (2022): 129-140

引用0浏览0引用

A Collaborative Analysis by Clinical Trial Sponsors and Academic Experts of Anti-transgene SAEs in Studies of Gene Therapy for DMD

Carsten G. Bonnemann,Beth A. Belluscio,Serge Braun,Carl Morris,Teji Singh,Francesco Muntoni

MOLECULAR THERAPY（2022）

引用1浏览0引用

IGNITE DMD Study of SGT-001 Microdystrophin Gene Therapy for Duchenne Muscular Dystrophy: Long-Term Outcomes and Biomarker Update

Carl A. Morris, Roxana Donisa Dreghici,Susan Redican, Jeffry Lawrence,Kristy J. Brown, Fei Wang,Patrick Gonzalez,Joel S. Schneider, Cathryn Clary,Perry B. Shieh,Barry J. Byrne

MOLECULAR THERAPY（2022）

引用0浏览0引用

Continued In Vitro and In Vivo Characterization of Novel AAV Vectors Engineered for Muscle Gene Delivery

Jennifer Green,Tiffany Willacy,Jessica Boehler, Alina Dhruva,Hui Meng,Margaret Beatka,Emily Ott,Mariah Prom,Michael W. Lawlor,Peter Pechan,Carl Morris

MOLECULAR THERAPY（2021）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn